Leveraging Glycan Sequencing to Transform Cancer Diagnostics
See the problem for yourself.
Standard PSA prostate cancer screening leads to 750,000 unnecessary biopsies per year. We are building a test to stop that.
We don’t just detect PSA. We decode it.
Follow Our Research Updates
